ALTERATIONS OF T-CELL REPERTOIRE AFTER BONE-MARROW TRANSPLANTATION - CHARACTERIZATION OF OVER-REPRESENTED SUBSETS

被引:0
|
作者
GASCHET, J
DENIS, C
MILPIED, N
HALLET, MM
ROMAGNE, F
NECKER, A
VIVIEN, R
DAVIDAMELINE, J
DAVODEAU, F
BONNEVILLE, M
VIE, H
机构
[1] INST BIOL,INSERM,U211,F-44035 NANTES,FRANCE
[2] CHR NANTES,INST BIOL,F-44035 NANTES,FRANCE
[3] CHR NANTES,SERV HEMATOL,NANTES,FRANCE
[4] IMMUNOTECH SA,MARSEILLE,FRANCE
关键词
BONE MARROW TRANSPLANTATION; T CELL RECONSTITUTION; TCR-V SUBSETS;
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We recently demonstrated that frequencies of T cell receptor-V (TcR-V)-specific subsets are frequently altered after both allogeneic and autologous BMT. The data reported here describe several characteristics of altered T cell subsets: (i) their capacity to endure peripherally, (ii) their correspondence to clonal donor T cell subsets, (iii) the origin of the clone (in one case amenable to analysis) from a mature T cell and not from new lymphopoiesis, and (iv) the presence of such a clone throughout a year of follow-up in a patient with chronic graft-versus-host disease (GVHD) in whom it represented up to 1/10th of CD3(+) peripheral blood lymphocytes (PBL) and was found to be host-reactive. Taken together, these findings provide direct evidence for the oligoclonality of a large proportion of the peripheral T cell repertoire in patients subsequent to bone marrow transplantation, possibly accounting for their frequent depressed immune status. Moreover, the anti-host reactivity demonstrated in a clone from the patient with chronic GVHD strongly suggests that an oligoclonal response can be linked to a pathological process.
引用
收藏
页码:427 / 435
页数:9
相关论文
共 50 条
  • [41] Regional differences in performance of bone marrow transplantation, care-resource use and outcome for adult T-cell leukaemia in Japan
    Maeda, Toshiki
    Babazono, Akira
    Nishi, Takumi
    Matsuda, Shinya
    Fushimi, Kiyohide
    Fujimori, Kenji
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [42] SECRETION OF LEUKEMIA INHIBITORY FACTOR AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - A STUDY OF CD4(+) AND CD8(+) TCR-ALPHA-BETA(+) T-CELL CLONES DERIVED FROM 4 LEUKEMIA PATIENTS
    BRUSERUD, O
    HAMANN, W
    PAWELEC, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (02) : 106 - 110
  • [43] Epstein-Barr virus-specific T-cell cytotoxicity is mediated through the perforin pathway in patients with lymphoproliferative disorders after allogeneic bone marrow transplantation
    Yoshimi, A
    Tsuge, I
    Namizaki, H
    Hoshino, Y
    Kimura, H
    Takahashi, Y
    Watanabe, N
    Kuzushima, K
    Kojima, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (03) : 710 - 715
  • [44] An irradiation-free nonmyeloablative bone marrow transplantation model: Importance of the balance between donor T-cell number and the intensity of conditioning
    Kuwatani, M
    Ikarashi, Y
    Mineishi, S
    Asaka, M
    Wakasugi, H
    TRANSPLANTATION, 2005, 80 (09) : 1145 - 1152
  • [45] Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in adenosine-deaminase severe combined immunodeficiency
    Cancrini, Caterina
    Ferrua, Francesca
    Scarselli, Alessia
    Brigida, Immacolata
    Romiti, Maria Luisa
    Barera, Graziano
    Finocchi, Andrea
    Roncarolo, Maria Grazia
    Caniglia, Maurizio
    Aiuti, Alessandro
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (10): : 1778 - 1782
  • [46] PH+ ACUTE MYELOGENOUS LEUKEMIA WITH T(711)(P15P15) AND CLONAL EVOLUTION IN RELAPSE AFTER BONE-MARROW TRANSPLANTATION
    MIURA, I
    NISHINARI, T
    HASHIMOTO, K
    NIMURA, T
    TAKATSU, H
    NIITSU, H
    HIROKAWA, M
    KUWAYAMA, A
    NISHIMURA, S
    MIURA, AB
    ACTA HAEMATOLOGICA, 1993, 90 (03) : 148 - 150
  • [47] CMV-ANTIGENEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - CORRELATION OF CMV-ANTIGEN POSITIVE CELL NUMBERS WITH TRANSPLANT-RELATED MORTALITY
    BACIGALUPO, A
    TEDONE, E
    ISAZA, A
    SORACCO, M
    VANLINT, MT
    SANNA, A
    FRASSONI, F
    OCCHINI, D
    GUALANDI, F
    LAMPARELLI, T
    FIGARI, O
    BENVENUTO, F
    RAFFO, MR
    MARMONT, AM
    BONE MARROW TRANSPLANTATION, 1995, 16 (01) : 155 - 161
  • [48] ALTERATIONS OF GLYCOSPHINGOLIPID-BASED BLOOD-GROUP ANTIGEN EXPRESSION ON ERYTHROCYTES AND IN PLASMA STUDIED ON CONSECUTIVE SAMPLES AFTER A BLOOD GROUP-O TO A BONE-MARROW TRANSPLANTATION
    LINDSTROM, K
    SHANWELL, A
    JACOBSSON, A
    LONNQVIST, B
    SAMUELSSON, BE
    GLYCOBIOLOGY, 1992, 2 (06) : 529 - 534
  • [49] GENERATION OF DONOR-DERIVED ANTILEUKEMIC CYTOTOXIC T-LYMPHOCYTE RESPONSES FOR TREATMENT OF RELAPSED LEUKEMIA AFTER ALLOGENEIC HLA-IDENTICAL BONE-MARROW TRANSPLANTATION
    FALKENBURG, JHF
    FABER, LM
    VANDENELSHOUT, M
    VANLUXEMBURGHEIJS, SAP
    HOOFTMANDENOTTER, A
    SMIT, WM
    VOOGT, PJ
    WILLEMZE, R
    JOURNAL OF IMMUNOTHERAPY, 1993, 14 (04): : 305 - 309
  • [50] Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: implications for treatment
    Bozzi, F
    Lefranc, G
    Villa, A
    Badolato, R
    Schumacher, RF
    Khalil, G
    Loiselet, J
    Bresciani, S
    O'Shea, JJ
    Vezzoni, P
    Notarangelo, LD
    Candotti, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (05) : 1363 - 1366